Key facts
- GelSana’s last known valuation is $32.7M (Mar 2026).
- It has raised $2.8M.
- Notable investors include Plug and Play Tech Center, MedTech Innovator, National Institutes of Health, AFWERX, Innosphere Ventures — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for GelSana
- ·The full record, as it builds
Funding rounds
No funding rounds for GelSana are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GelSana
Developer of a biomaterial technology designed to improve wound healing by reducing inflammation and promoting controlled drug delivery. The company's technology offers elastic wound dressings that conform to any wound and epidermal layers post-healing, enabling healthcare providers to treat chronic wounds with reduced risk of infection.
- Sector
- Healthcare
- HQ
- Aurora, CO, United States
- Founded
- 2020
- Employees
- 7
- Website
- gelsanatherapeutics.com/
- Ownership
- Privately Held (backing)
GelSana doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GelSana shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GelSana in its N-PORT filings yet. We sweep new filings monthly.